To explore the mechanism by which CXCL12 secreted by CAFs induces sorafenib resistance in HCC cells, we assessed two datasets of cancer cells treated with CXCL12 protein (GSE15893 and GSE40017) in the GEO database. This evidence concerns the gene CXCL12 and hepatocellular carcinoma.